Scott Fidel
Stock Analyst at Stephens & Co.
(2.24)
# 2,560
Out of 4,784 analysts
182
Total ratings
100%
Success rate
3.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health Partners | Reiterates: Overweight | $22 | $13.20 | +66.67% | 3 | Mar 26, 2025 | |
| ADUS Addus HomeCare | Reiterates: Overweight | $142 | $97.30 | +45.94% | 12 | Mar 12, 2025 | |
| PNTG The Pennant Group | Reiterates: Overweight | $38 | $24.61 | +54.41% | 18 | Mar 11, 2025 | |
| AMED Amedisys | Reiterates: Equal-Weight | $101 | $92.70 | +8.95% | 13 | Mar 4, 2025 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $210 → $223 | $186.18 | +19.78% | 10 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $18.30 | -7.10% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $60.04 | +21.59% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $516.04 | +30.80% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $10.91 | +184.14% | 4 | Nov 18, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $325.04 | +26.14% | 12 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $128.74 | +29.72% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $20.15 | +4.22% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $264.58 | -5.51% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $432.00 | +42.36% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $100.78 | +4.19% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $322.85 | -0.88% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $133.14 | -8.37% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $30.12 | +205.44% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $342.16 | -18.17% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $1.40 | +6,710.04% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $5.37 | -72.07% | 3 | Nov 11, 2022 |
Ardent Health Partners
Mar 26, 2025
Reiterates: Overweight
Price Target: $22
Current: $13.20
Upside: +66.67%
Addus HomeCare
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $97.30
Upside: +45.94%
The Pennant Group
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $24.61
Upside: +54.41%
Amedisys
Mar 4, 2025
Reiterates: Equal-Weight
Price Target: $101
Current: $92.70
Upside: +8.95%
Universal Health Services
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $210 → $223
Current: $186.18
Upside: +19.78%
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $18.30
Upside: -7.10%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $60.04
Upside: +21.59%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $516.04
Upside: +30.80%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $10.91
Upside: +184.14%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $325.04
Upside: +26.14%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $128.74
Upside: +29.72%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $20.15
Upside: +4.22%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $264.58
Upside: -5.51%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $432.00
Upside: +42.36%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $100.78
Upside: +4.19%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $322.85
Upside: -0.88%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $133.14
Upside: -8.37%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $30.12
Upside: +205.44%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $342.16
Upside: -18.17%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $1.40
Upside: +6,710.04%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $5.37
Upside: -72.07%